Daiichi Sankyo (OTCMKTS:DSNKY) Downgraded to “Strong Sell” Rating by Zacks Research

Zacks Research cut shares of Daiichi Sankyo (OTCMKTS:DSNKY) from a hold rating to a strong sell rating in a research report released on Wednesday,Zacks.com reports.

Daiichi Sankyo Stock Performance

Shares of DSNKY stock opened at $22.71 on Wednesday. The firm’s 50 day moving average is $24.31 and its 200 day moving average is $24.38. The stock has a market capitalization of $43.02 billion and a P/E ratio of 21.42. Daiichi Sankyo has a 12 month low of $20.92 and a 12 month high of $33.21. The company has a current ratio of 2.31, a quick ratio of 1.60 and a debt-to-equity ratio of 0.06.

About Daiichi Sankyo

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.